-
cover and contents
Abstract
(
83)
PDF (20884 KB) (
90
)
2025, Vol.58(11): 0–0 doi: https://doi.org/10.35541/cjd.20220740
-
Therapeutic strategies for psoriasis: current status and progress
Abstract
(
84)
PDF (7793 KB) (
2
)
2025, Vol.58(11): 1003–1008 doi: https://doi.org/10.35541/cjd.20250262
-
Psoriasis-atopic dermatitis overlap phenotype: immune dysregulation mechanisms and emerging clinical insights
Abstract
(
100)
PDF (15342 KB) (
9
)
2025, Vol.58(11): 1009–1014 doi: https://doi.org/10.35541/cjd.20250219
-
Treatment and diagnosis of generalized pustular psoriasis: advances, challenges, and prospects
Abstract
(
38)
PDF (6462 KB) (
1
)
2025, Vol.58(11): 1015–1019 doi: https://doi.org/10.35541/cjd.20250249
-
Clinical efficacy and safety of a domestic calcipotriol/betamethasone dipropionate ointment in the treatment of stable plaque psoriasis: a multicenter, randomized, double-blind, controlled study
Abstract
(
60)
PDF (8829 KB) (
46
)
2025, Vol.58(11): 1020–1026 doi: https://doi.org/10.35541/cjd.20250379
-
Comparative analysis of clinical characteristics between psoriasis-atopic dermatitis overlap phenotype and psoriasis vulgaris: a single-center retrospective exploratory study
Abstract
(
71)
PDF (15356 KB) (
4
)
2025, Vol.58(11): 1027–1033 doi: https://doi.org/10.35541/cjd.20250416
-
Interleukin-27 exerts a protective effect against psoriasis by inhibiting the secretion of interleukin-17A from T cells: a mechanistic study
Abstract
(
52)
PDF (14995 KB) (
1
)
2025, Vol.58(11): 1034–1041 doi: https://doi.org/10.35541/cjd.20240437
-
Investigations into the mechanisms underlying the regulatory effect of EPHA2 on keratinocyte proliferation and differentiation via ERK pathway in psoriasis
Abstract
(
42)
PDF (24401 KB) (
1
)
2025, Vol.58(11): 1042–1052 doi: https://doi.org/10.35541/cjd.20240655
-
Characteristics of psoriatic arthritis: a cross-sectional study based on a cohort of 530 patients
Abstract
(
45)
PDF (7606 KB) (
2
)
2025, Vol.58(11): 1053–1058 doi: https://doi.org/10.35541/cjd.20250198
-
A cross-sectional study on knowledge, treatment needs, and optimization of chronic disease management pathways regarding biologics in patients with psoriasis
Abstract
(
47)
PDF (6364 KB) (
3
)
2025, Vol.58(11): 1059–1063 doi: https://doi.org/10.35541/cjd.20250269
-
Huanglian Jiedu decoction combined with Xijiao Dihuang decoction for the treatment of psoriasis via influencing fibroblast activation-mediated keratinocyte proliferation: a mechanistic study
Abstract
(
40)
PDF (17819 KB) (
0
)
2025, Vol.58(11): 1064–1074 doi: https://doi.org/10.35541/cjd.20250033
-
Efficacy and safety of biologics in plaque psoriasis patients with thrombocytopenia: a single-center retrospective cohort study
Abstract
(
45)
PDF (6760 KB) (
0
)
2025, Vol.58(11): 1075–1079 doi: https://doi.org/10.35541/cjd.20230400
-
Efficacy and safety of spesolimab in the treatment of six cases of generalized pustular psoriasis: a retrospective analysis
Abstract
(
232)
PDF (5923 KB) (
4
)
2025, Vol.58(11): 1080–1082 doi: https://doi.org/10.35541/cjd.20240440
-
Two cases of erythrodermic psoriasis treated with apremilast
Abstract
(
251)
PDF (7153 KB) (
20
)
2025, Vol.58(11): 1083–1085 doi: https://doi.org/10.35541/cjd.20230542
-
Severe plaque psoriasis in a case of Down syndrome
Abstract
(
186)
PDF (4684 KB) (
537
)
2025, Vol.58(11): 1085–1086 doi: https://doi.org/10.35541/cjd.20230105
-
Three cases of painful skin ulcers following inappropriate self-use of methotrexate by patients with psoriasis
Abstract
(
229)
PDF (5558 KB) (
665
)
2025, Vol.58(11): 1087–1089 doi: https://doi.org/10.35541/cjd.20220288
-
Psoriasis relapse following biologic therapy: current status
Abstract
(
594)
PDF (7991 KB) (
25
)
2025, Vol.58(11): 1090–1095 doi: https://doi.org/10.35541/cjd.20230301
-
Tyrosine kinase 2 inhibitors for plaque psoriasis: mechanisms of action and advances in clinical research
Abstract
(
436)
PDF (5160 KB) (
783
)
2025, Vol.58(11): 1095–1098 doi: https://doi.org/10.35541/cjd.20220740
